01406nam 2200373Ia 450 991069939580332120230902162117.0(CKB)5470000002401954(OCoLC)496297445(EXLCZ)99547000000240195420100108d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] adverse reactions section of labeling for human prescription drug and biological products, content and formatRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :Center for Biologics Evaluation and Research,[2006]1 online resource (13 pages)"Labeling.""January 2006."Guidance for industry DrugsSide effectsUnited StatesDrugsLabelingGovernment policyUnited StatesDrugsSide effectsDrugsLabelingGovernment policyCenter for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910699395803321Guidance for industry3434577UNINA